Physician profile
Amy H Eppstein
NPI 1962761122
$533.29
in general payments reported to CMS, 2019-2025
11 companies · $17.30 in 2025
The $17.30 reported for 2025 was less than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $146 · 2020: $93.43 · 2021: $77.44 · 2022: $139 · 2023: $15.93 · 2024: $43.40 · 2025: $17.30.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $76.63.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $76.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $116.08 | 2019-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $107.58 | 2020-2024 | Xifaxan |
| Glaxosmithkline, LLC. | $73.84 | 2019-2025 | Shingrix, Pediarix, Arexvy |
| Sanofi Pasteur INC. | $60.31 | 2019-2022 | |
| Sanofi-Aventis U.S. LLC | $47.66 | 2021-2023 | |
| Amarin Pharma, INC. | $39.70 | 2019 | |
| Merck Sharp & Dohme LLC | $23.13 | 2021 | |
| Dexcom, INC. | $19.55 | 2022 | |
| Daiichi Sankyo INC. | $16.92 | 2019 | |
| Grifols USA, LLC | $14.54 | 2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $13.98 | 2024 | Jardiance |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Eppstein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.